City

Izmir (2)

Many Locations (1)

Condition

Bacterial Vaginosis (3)

Trichomonal Vaginitis (3)

Candidal Vulvovaginitis (2)

Mixed Vaginal Infections (2)

Vaginal Candidiasis (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Bayer (1)

Ege University (1)

Exeltis Turkey (1)

Collaborator

Monitor CRO (2)

Exeltis Turkey (1)

Intervention

gynomax® xl vaginal ovule (2)

evegyn a (1)

evegyn b (1)

metronidazole/miconazole (neo-penotran forte, bay86-5276) (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

trichomonal vaginitis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis Trial in Izmir (EVEGYN A, EVEGYN B, Gynomax® XL Vaginal

Completed

Trichomonal Vaginitis
+3 more

EVEGYN A
+2 more

Izmir, Turkey

Ege University Family Planning and Infertility Application and R

Sep 25, 2023

Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis Trial in Izmir (Gynomax® XL Vaginal Ovule)

Completed

Trichomonal Vaginitis
+3 more

Gynomax® XL Vaginal Ovule

İzmir, Turkey

Ege University Family Planning and Infertility Application and R

Jan 30, 2020

Observational Program Neo-Penotran® Forte

Completed

Vaginal Candidiasis
+2 more

Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)

Many Locations, Kazakhstan

(unnamed)

Jul 22, 2016